Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Dunne, Dana W ^a   Shaw, Albert ^a   Bockenstedt, Linda K ^a   Allore, Heather G ^a   Chen, Shu ^a   Malawista, Stephen E ^a   Leng, Lin ^a   Mizue, Yuka ^b   Piecychna, Marta ^a   Zhang, Lin ^a   Towle, Virginia ^a   Bucala, Richard ^a   Montgomery, Ruth R ^a   Fikrig, Erol ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sapporo Immuno Diagnostic Laboratory   (Japan)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 4;

EID: 77955333707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011343     Document Type: Article

References (35)

1. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388(6640): 394-7.
2. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396): 2085-8.
3. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4): 783-801.
4. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5(10): 987-95.
5. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449(7164): 819-26.
6. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416(6881): 603-7.
7. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50(6): 1861-72.
8. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J (1982) Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216(4544): 429-31.
9. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell R A, et al. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3): 417-28.
10. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6(11): 823-35.
11. Sacre SM, Lo A, Gregory B, Simmonds RE, Williams L, Feldmann M, et al. (2008) Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol 181(11): 8002-9.
12. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, et al. (2006) Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 176(11): 7021-7.
13. van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, et al. (2007) Age-associated defect in human TLR-1/2 function. J Immunol 178(2): 970-5.
14. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, et al. (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nat Med 8(8): 878-84.
15. Kong KF, Delroux K, Wang X, Qian F, Arjona A, et al. (2008) Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 82(15): 7613-23.
16. Mizue Y, Ghani S, Leng L, McDonald C, Kong P, et al. (2005) Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci USA 102(40): 14410-5.
17. McCullagh P, Nelder JA (1989) Generalized Linear Models. London: Chapman and Hall.
18. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics; 38: 963-974.
19. Verbeke G, Molenberghs G (1997) Linear mixed models in practice, in A SAS oriented approach, G. Verbeke and G. Molenberghs, Editors. Springer, New York.
20. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a doubleedged sword. Nat Rev Immunol 3(9): 745-56.
21. Chen YC, Wang SY (2002) Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76(19): 9877-87.
22. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, et al. (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3(3): 170-6.
23. Berdeli A, Ozyurek AR, Ulger Z, Gurses D, Levent E, et al. (2006) Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int 26(8): 726-31.
24. Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, et al. (2007) Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol 34(5): 927-36.
25. Martinez A, Orozco G, Varade J, Sanchez Lopez M, Pascual D, et al. (2007) Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol 68(9): 744-7.
26. Morand EF, Leech M, Weedon H, Metz C, Bucala R, et al. (2002) Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 41(5): 558-62.
27. Kang I, Park SH (2003) Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 15(5): 528-34.
28. Franklin J, Lunt M, Bunn D, Symmons D, Silman A (2007) Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 66(3): 308-12.
29. Roger T, David J, Glauser MP, Calandra T (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414(6866): 920-4.
30. Roger T, Froidevaux C, Martin C, Calandra T (2003) Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4). J Endotoxin Res 9(2): 119-23.
31. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6): 1895-902.
32. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, et al. (2000) Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 275(1): 444-50.
33. Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF (2001) Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 44(6): 1273-80.
34. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, et al. (2003) Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 48(7): 1881-9.
35. Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, et al. (2005) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 52(10): 3020-9.